Literature DB >> 2823025

Evidence for the involvement of DNA topoisomerase II in neutrophil-granulocyte differentiation.

G E Francis1, J J Berney, P S North, Z Khan, E L Wilson, P Jacobs, M Ali.   

Abstract

Agents that slow cellular proliferation usually stimulate myeloid differentiation. The demonstration in this report of an anomalous inhibitory behavior of the epipodophyllotoxin VP16-213, an agent known to inhibit the enzyme DNA topoisomerase II, prompted us to investigate the role of this enzyme in both changes in DNA supercoiling and in DNA strand breakage and reunion events occurring during the induction of neutrophil-granulocyte differentiation. We recently reported that retinoic acid, an inducer of granulocytic differentiation, stimulates transient relaxation of DNA supercoiling. We now show that this is associated with the formation of small numbers of protein-linked DNA breaks (a characteristic of topoisomerase reactions). Both events are perturbed by VP16-213, and since this agent inhibits subsequent differentiation, these observations raise the possibility of a role for DNA topoisomerase II in granulocytic differentiation. The possible relevance of these findings to mechanisms of leukemogenesis is discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2823025

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  3 in total

1.  Model for MLL translocations in therapy-related leukemia involving topoisomerase IIβ-mediated DNA strand breaks and gene proximity.

Authors:  Ian G Cowell; Zbyslaw Sondka; Kayleigh Smith; Ka Cheong Lee; Catriona M Manville; Malgorzata Sidorczuk-Lesthuruge; Holly Ashlene Rance; Kay Padget; Graham Hunter Jackson; Noritaka Adachi; Caroline A Austin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-21       Impact factor: 11.205

Review 2.  Mechanism of generation of therapy related leukemia in response to anti-topoisomerase II agents.

Authors:  Ian G Cowell; Caroline A Austin
Journal:  Int J Environ Res Public Health       Date:  2012-05-31       Impact factor: 3.390

3.  Aberrant DNA topoisomerase II activity, radioresistance and inherited susceptibility to cancer.

Authors:  J M Cunningham; G E Francis; M J Holland; K F Pirollo; E H Chang
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.